Related Experiment Video
Updated: Feb 6, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Clinical adverse effects of sodium-glucose cotransporter 2 inhibitors: Protocol for a systematic review and
Hao Li1, Fang-Hong Shi, Shi-Ying Huang
1Department of Pharmacy, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, P.R. China.
Background:
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel class of oral antidiabetic drugs, which mainly increase urinary glucose excretion through reducing renal glucose reabsorption. There is still a concern about the overall safety profile of SGLT2 inhibitors. In this systematic review and meta-analysis, we will assess the clinical adverse effects of SGLT2 inhibitors in type 2 diabetes mellitus.
Methods:
This systemic review and meta-analysis described in this protocol will be conducted to follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. We will search Medline, EMbase, the Cochrane library and the ClinicalTrials.gov Website from 1946 to June 2018. Studies will be screened by title, abstract, and full text independently in duplicate. Double-blinded, placebo-controlled, and randomized controlled trials reporting safety data of SGLT2 inhibitors will be eligible for inclusion. Outcomes will include adverse events (AEs) varying degrees and AEs occurring in ≥3% patients or AEs aroused concerns by the Food and Drug Administration (FDA). The assessment of risk bias and data synthesis will be performed using STATA software (version12, Statacorp, College Station, TX). Outcomes will be reported by risk ratios for dichotomous outcomes and weighted mean difference (WMD) for continuous outcomes and their 95% confidence intervals. Subgroup, sensitivity, regression analyses will be performed to evaluate intertrial heterogeneity and bias of the results. I statistic will be used to evaluate heterogeneity among studies.
Results:
This systemic review and meta-analysis will evaluate AEs occurring in ≥3% patients or AEs aroused concerns by the FDA of SGLT2i as compared to placebo.
Conclusion:
Our study will provide a comprehensive picture of AEs of SGLT2 inhibitors.
Insights
This systematic review assesses the safety of Sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 2 diabetes. The analysis focuses on clinical adverse events (AEs) to provide a comprehensive safety profile.
Area of Science:
- Pharmacology
- Endocrinology
- Clinical Medicine
Background:
- Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new oral antidiabetic drug class.
- These drugs increase urinary glucose excretion by reducing renal glucose reabsorption.
- Concerns exist regarding the overall safety profile of SGLT2 inhibitors.
Purpose of the Study:
- To systematically review and meta-analyze the clinical adverse effects of SGLT2 inhibitors.
- To assess the safety of SGLT2 inhibitors in patients with type 2 diabetes mellitus.
- To provide a comprehensive picture of adverse events associated with SGLT2 inhibitors.
Main Methods:
- Systematic review and meta-analysis following PRISMA guidelines.
- Searched Medline, EMbase, Cochrane Library, and ClinicalTrials.gov (1946-June 2018).
- Included double-blinded, placebo-controlled, randomized controlled trials reporting safety data; analyzed adverse events (AEs) occurring in ≥3% of patients or those of concern to the FDA.
Main Results:
- The meta-analysis will evaluate adverse events (AEs) occurring in ≥3% of patients.
- AEs of concern to the FDA will also be evaluated.
- Results will be compared between SGLT2 inhibitors and placebo.
Conclusions:
- This study will offer a comprehensive overview of the adverse events associated with SGLT2 inhibitors.
- The findings will contribute to a better understanding of the safety profile of these antidiabetic drugs.
More Related Videos
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview